Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 61751-61800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04630392
Effects of Treadmill Training and Whole-body Vibration in Children With Cerebral Palsy
NARecruiting
20 participants
Started: Nov 12, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03300492
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
PHASE1/PHASE2Recruiting
10 participants
Started: Nov 12, 2018 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05852522
Molecularly Aided Stratification for Tumor Eradication Research
N/ARecruiting
10,000 participants
Started: Nov 11, 2018 · Completed: Oct 31, 2029
2 conditions2 sponsors1 location
NCT06130176
Single-step Functional Sinus Endoscopy and Transoral Surgery
NARecruiting
36 participants
Started: Nov 11, 2018 · Completed: Jul 1, 2026
1 condition3 sponsors1 location
NCT05774834
Neural Bases of Decision-making in Healthy Individuals
N/ARecruiting
150 participants
Started: Nov 10, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03865472
rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers
NARecruiting
300 participants
Started: Nov 10, 2018 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT03698149
ECoG BMI for Motor and Speech Control
NARecruiting
3 participants
Started: Nov 9, 2018 · Completed: Aug 15, 2030
5 conditions2 sponsors1 location
NCT04239144
Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease
NARecruiting
45 participants
Started: Nov 9, 2018 · Completed: Mar 9, 2026
2 conditions2 sponsors1 location
NCT04160429
Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations
N/ARecruiting
100 participants
Started: Nov 9, 2018 · Completed: Jul 30, 2029
2 conditions2 sponsors1 location
NCT04947098
Prevent Cancer- Greenville
N/ARecruiting
1,000 participants
Started: Nov 8, 2018 · Completed: Nov 8, 2029
2 conditions1 sponsor1 location
NCT04048278
Lidocaine Infusion in Pancreatic Cancer
EARLY_PHASE1Recruiting
46 participants
Started: Nov 8, 2018 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT03687814
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NARecruiting
78 participants
Started: Nov 8, 2018 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT03394417
StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
NARecruiting
100 participants
Started: Nov 8, 2018 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT03741673
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
PHASE3Recruiting
180 participants
Started: Nov 8, 2018 · Completed: Jan 31, 2027
2 conditions2 sponsors1 location
NCT04004312
Single Fractions SBRT for Prostate Cancer
NARecruiting
12 participants
Started: Nov 7, 2018 · Completed: Dec 20, 2027
1 condition2 sponsors1 location
NCT04242602
Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury
NARecruiting
30 participants
Started: Nov 6, 2018 · Completed: Jan 31, 2030
3 conditions3 sponsors1 location
NCT03769415
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
NARecruiting
500 participants
Started: Nov 6, 2018 · Completed: Dec 15, 2030
1 condition3 sponsors2 locations
NCT03563417
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NARecruiting
1,560 participants
Started: Nov 6, 2018 · Completed: Nov 1, 2032
2 conditions1 sponsor27 locations
NCT03825250
The Val-CARD Trial
PHASE1/PHASE2Recruiting
122 participants
Started: Nov 6, 2018 · Completed: Oct 7, 2024
3 conditions1 sponsor1 location
NCT04045587
International Severe Asthma Registry: Canadian Cohort
N/ARecruiting
714 participants
Started: Nov 6, 2018 · Completed: Dec 31, 2028
1 condition10 sponsors12 locations
NCT03818334
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
PHASE2/PHASE3Recruiting
50 participants
Started: Nov 6, 2018 · Completed: Nov 1, 2026
5 conditions1 sponsor1 location
NCT04599621
Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome
N/ARecruiting
3 participants
Started: Nov 5, 2018 · Completed: Dec 28, 2027
1 condition1 sponsor1 location
NCT03649048
Low-Dose Weekly vs High-Dose Cisplatin
NARecruiting
100 participants
Started: Nov 5, 2018 · Completed: Sep 30, 2028
1 condition1 sponsor3 locations
NCT03415763
Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
PHASE3Recruiting
764 participants
Started: Nov 5, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05268783
Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk
NARecruiting
1,000 participants
Started: Nov 5, 2018 · Completed: Dec 31, 2029
1 condition1 sponsor7 locations
NCT03705585
CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
PHASE4Recruiting
240 participants
Started: Nov 5, 2018 · Completed: May 31, 2029
1 condition1 sponsor1 location
NCT03366116
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
PHASE1Recruiting
65 participants
Started: Nov 5, 2018 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT03961373
Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer
PHASE3Recruiting
539 participants
Started: Nov 5, 2018 · Completed: Nov 1, 2028
1 condition1 sponsor1 location
NCT03856034
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
NARecruiting
12 participants
Started: Nov 2, 2018 · Completed: Dec 31, 2027
4 conditions3 sponsors2 locations
NCT03755401
Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy
NARecruiting
75 participants
Started: Nov 2, 2018 · Completed: May 31, 2026
1 condition6 sponsors1 location
NCT03774446
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
PHASE2Recruiting
13 participants
Started: Nov 2, 2018 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT04362592
In-Utero Endoscopic Correction of Spina Bifida
NARecruiting
110 participants
Started: Nov 2, 2018 · Completed: Oct 31, 2031
3 conditions2 sponsors2 locations
NCT03349762
Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
N/ARecruiting
3,060 participants
Started: Nov 2, 2018 · Completed: Jun 30, 2028
1 condition1 sponsor22 locations
NCT05704010
Videocapsule Endoscopy in Lynch Syndrome
NARecruiting
100 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2026
8 conditions4 sponsors1 location
NCT03755739
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
PHASE2/PHASE3Recruiting
200 participants
Started: Nov 1, 2018 · Completed: Nov 1, 2036
10 conditions1 sponsor1 location
NCT04675892
Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers
NARecruiting
60 participants
Started: Nov 1, 2018 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT04791891
Quebec Low Back Pain Study: Core Dataset
N/ARecruiting
10,000 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT03731442
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
PHASE3Recruiting
300 participants
Started: Nov 1, 2018 · Completed: Oct 31, 2027
1 condition7 sponsors1 location
NCT02991248
Improve Dynamic Lateral Balance of Humans With SCI
NARecruiting
54 participants
Started: Nov 1, 2018 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03266640
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
PHASE2Recruiting
20 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2027
2 conditions9 sponsors9 locations
NCT06361264
Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide
EARLY_PHASE1Recruiting
20 participants
Started: Nov 1, 2018 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT03266627
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
PHASE2Recruiting
20 participants
Started: Nov 1, 2018 · Completed: Dec 31, 2027
2 conditions10 sponsors10 locations
NCT03690986
VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
PHASE1Recruiting
50 participants
Started: Nov 1, 2018 · Completed: Nov 30, 2027
1 condition2 sponsors1 location
NCT05778773
OUTcomes Evaluation of Current Therapeutic STrategies for Severe Aortic Valve steNosis anD the agING Population in ITALY
N/ARecruiting
1,000 participants
Started: Nov 1, 2018 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT06725719
Translocator Protein PET/CT in Various TSPO-Related Disease
N/ARecruiting
200 participants
Started: Nov 1, 2018 · Completed: Dec 1, 2027
3 conditions2 sponsors2 locations
NCT03756675
Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia
N/ARecruiting
45 participants
Started: Nov 1, 2018 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT03747133
SABR for Renal Tumors
NARecruiting
45 participants
Started: Nov 1, 2018 · Completed: Nov 30, 2027
1 condition1 sponsor2 locations
NCT06195345
Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
N/ARecruiting
1,000 participants
Started: Nov 1, 2018 · Completed: Nov 30, 2025
5 conditions1 sponsor1 location
NCT03769129
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
NARecruiting
100 participants
Started: Nov 1, 2018 · Completed: Nov 1, 2029
1 condition1 sponsor1 location
NCT03783624
Measuring the Effects of Complementary Therapies in Chronic Neuropathic Pain
NARecruiting
72 participants
Started: Nov 1, 2018 · Completed: Oct 31, 2024
1 condition1 sponsor1 location